Showing 9091-9100 of 20379 results for "".
- Intraoperative Dexmedetomidine Effectively Controls Perioperative Blood Sugar in Diabetics Undergoing Cardiac Surgery: Studyhttps://reachmd.com/news/intraoperative-dexmedetomidine-effectively-controls-perioperative-blood-sugar-in-diabetics-undergoing-cardiac-surgery-study/2467581/Researchers have found that intraoperative infusion of dexmedetomidine is highly effective in managing perioperative blood glucose levels and reducing insulin requirements in diabetic patients undergoing cardiac surgery. This study was recently published in the journal Annals of Car
- Evolocumab Lowers First Event Risk in Diabetes Primary Preventionhttps://reachmd.com/news/evolocumab-lowers-first-event-risk-in-diabetes-primary-prevention/2486625/In VESALIUS-CV, investigators reported lower first major cardiovascular event rates with evolocumab than with placebo in a prespecified diabetes subgroup without known significant atheroscleros
- Exploring AI Simulation in Diabetes Remission Prediction for Bariatric Surgeryhttps://reachmd.com/news/ai-simulation-diabetes-remission-bariatric-surgery/2484976/A proof-of-concept study explored the use of AI-simulated patients to select diabetes remission prediction models for bariatric surgery and found it can improve model fit for
- miR-191-5p: Key Player in Angiogenesis Regulation in Diabetic Foot Ulcershttps://reachmd.com/news/mir-191-5p-key-player-in-angiogenesis-regulation-in-diabetic-foot-ulcers/2484368/A study in the European Journal of Medical Research found that miR-191-5p is markedly upregulated in diabetic foot ulcers (DFU) and directly impairs angioge
- Study Links Sweet Tooth to Increased Risks of Depression, Diabetes, and Strokehttps://reachmd.com/news/study-links-sweet-tooth-to-increased-risks-of-depression-diabetes-and-stroke/2468419/New research from the University of Surrey reveals a significant link between having a sweet tooth and an elevated risk of depression, diabetes, and stroke. The study, published in the Journal of Translational Medicine, analyzed data from 180,000 participants in the UK Biobank to explore
- Phase I Clinical Insights on Obrixtamig: Targeting DLL3-Positive Cancershttps://reachmd.com/news/phase-i-clinical-insights-on-obrixtamig-targeting-dll3-positive-cancers/2483521/In the relentless pursuit to conquer aggressive forms of cancer, obrixtamig represents a beacon of hope for those battling DLL3-positive carcinomas. Small cell lung cancer (SCLC) presents unique challenges in oncologic care, with exploration extending to other DLL3‑positive neuroendocrine t
- Delix Plans Further Trials with Neuroplastogen After Positive Phase I Datahttps://reachmd.com/news/delix-plans-further-trials-with-neuroplastogen-after-positive-phase-i-data/2467418/
- AI Spotlights Hidden Diabetes Risk Before Traditional Testshttps://reachmd.com/news/ai-spotlights-hidden-diabetes-risk-before-traditional-tests/2476006/As demonstrated by an AI-driven diabetes model, complex patterns of glucose variability can flag patients at risk for diabetes even when traditional tests appear normal, underscoring an unde
- Health Canada Approves First Botulinum Toxin Type E for Aesthetic Usehttps://reachmd.com/news/health-canada-approves-first-botulinum-toxin-type-e-for-aesthetic-use/2487591/Health Canada has approved Boey (trenibotulinumtoxinE; Allergan Aesthetics, an AbbVie company) for the temporary improvement in the appearance of moderate-to-severe glabellar lines in adult patients, making it the first approved botulinum neurotoxin serotype E for aesthetic use and the first rapi
- Some Types of HPV May Affect Men's Fertility, New Study Suggestshttps://reachmd.com/news/some-types-of-hpv-may-affect-mens-fertility-new-study-suggests/2467949/Scientists have long considered that the world’s most common sexually transmitted infection, human papillomavirus, or HPV, may be a driver of infertility.Most research about HPV’s potential impact on fertility has focused on women. But in recent years, researchers have increasing